IP Verse

Peter Maccallum Cancer Institute competitive analysis

Loading summary...

Latest patents of Peter Maccallum Cancer Institute opposed by its competitors

Explore Peter Maccallum Cancer Institute's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 30, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP1827604
Nov 20, 2019Methods And Compositions For Adoptive Immunotherapy3

Latest publications and patents of Peter Maccallum Cancer Institute New

Explore the latest publications and patents granted to Peter Maccallum Cancer Institute, showcasing their recent innovations and technological advancements.

Last updated on: Oct 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Peter Maccallum Cancer Institute

EP1827604
Nov 20, 2019Methods And Compositions For Adoptive ImmunotherapyRevoked
EP2585060
Jan 24, 2018Stimulating Immune ResponseNo Opposition Filed Within Time Limit

Latest PTAB cases involving Peter Maccallum Cancer Institute

Discover the latest PTAB cases involving Peter Maccallum Cancer Institute, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Peter Maccallum Cancer Institute with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
PETER MACCALLUM CANCER INSTITUTE - 3 - -
GLAXOSMITHKLINE29112812
MATHYS & SQUIRE54 - - -
PATENT BOUTIQUE43 - - -